Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 6, 1996 - Issue 4
Submit an article Journal homepage
7
Views
3
CrossRef citations to date
0
Altmetric
Research

Section Review Central & Peripheral Nervous Systems: Mechanisms of apoptosis as drug targets in the central nervous system

Paul Spence Wyeth-Ayerst Research, CN-8000, Princeton, NJ, 08543-8000, USA
,
Rodrigo Franco Wyeth-Ayerst Research, CN-8000, Princeton, NJ, 08543-8000, USA
,
Andrew Wood Wyeth-Ayerst Research, CN-8000, Princeton, NJ, 08543-8000, USA
&
John A Moyer Wyeth-Ayerst Research, CN-8000, Princeton, NJ, 08543-8000, USA
Pages 345-366 | Published online: 29 Feb 2008

References to Primary Literature

  • ORRENIUS S: Apoptosis: molecular mechanisms and implications for human disease. J. Intern. Med. (1995) 237(6):529–536. Overview of the role of apoptosis in human disease including neurodegenerative disorders.
  • VAUX DL: Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA (1993) 90(3):786–789.
  • FtAFF MC: Social controls on cell survival and cell death.Nature (1992) 356(6368):397–400.
  • ALLSOPP TE, WYAIT S, PATERSON HF, DAVIES AM: Theproto-oncogene bcl-2 can selectively rescue neurotro-phic factor- dependent neurons from apoptosis. Cell (1993) 73(2):295–307.
  • KUMAR S: ICE-like proteases in apoptosis. Trends BioChem. Sci. (1995) 20(5):198–202. An informative review discussing ICE, its homologues and other members of the cysteine protease family. It also suggests possible apoptotic pathways.
  • HOCKENBERY D: Defining apoptosis. Am.J. Pathol. (1995) 146(1):16–19.
  • WYLLIE All: The genetic regulation of apoptosis. Carr. Opin. Genet. Dev. (1995) 5(1):97–104.
  • WYLLIE AH, ARENDS MJ, MORRIS RG, WALKER SW, EVAN G: The apoptosis endonuclease and its regulation. Semin. Immunol. (1992) 4(6):389–397.
  • DOWD DR: Calcium regulation of apoptosis. Adv. Second Messenger Phospboprotetn Res. (1995) 30:255–280.
  • RAB1ZADEH S, OH J, ZHONG L, YANG J, BITLER C, BUTCHER LL, BREDESEN DE: Induction of apoptosis by the low affinity NGF receptor. Science (1993) 261:345–358.
  • SMIT1I CA, FARRAH T, GOODWIN RG: The TNF receptor superfainily of cellular and viral proteins: activation, costimulation, and death. Cell (1994) 76:959-962. A mini-review which clearly describes the TNF receptor superfamily.
  • RABIZADEH S, IIREDESEN DE: Is p75NGFR involved in developmental neural cell death? Dev. Neurosci. (1994) 16(3-4): 207–211.
  • VERDI J M, BIRREN SJ, MANEZ CF, PERSSON H, KAPLANDR, BENEDETTI M, CHAO MV, ANDERSON DJ: p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAR cells. Neuron (1994) 12(4):733–745.
  • LOEB DM, MARAGOS J, MARTIN-ZANCA D, CHAO MV, PARADA LF, GREENE LA: The trk proto-oncogene rescues NGF responsiveness in mutant NGF non-responsive PC12 cell lines. Cell (1991) 66:961–966.
  • LORIGADOS L, SODERSTROM 5, EBENDAL T: Two-site enzyme immunoassay for beta NGF applied to human patient sera. J. Neurosci. Res. (1992) 32(3):329–339.
  • RABIZADEH S, HITLER CM, BUTCHER LL, BREDESEN DE: Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity. Proc. Natl. Acad. Sci. USA (1994) 91(22):10703–10706.
  • BEHL C, DAVIS JB, LESLEY R, SCHUBERT D: Hydrogen peroxide mediates amyloid beta protein toxicity. Cell (1994) 77(6):817–827.
  • TARTAGLIA LA, WEBER RF, FIGARI IS, REYNOLDS C, PAL-LADINO MA, JR., GOEDDEL DV: The two different recep-tors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. WA 88(20):9292–9296.
  • NAGATA S, GOLSTEIN P: The Pas death factor. Science (1995) 267(5203):1449–1456. A review which concentrates on the cell death promoting activity of the Fas ligand receptor interaction. Pathological conditions resulting from mutations of these proteins are also discussed.
  • TARTAGLIA LA, AYRES TM, WONG GH, GOEDDEL DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell (1993) 74(5):845–853.
  • GOLSTEIN P, MARGUET D, DEPRAETERE V: Homology between reaper and the cell death domains of Fas and TNER1. Cell (1995) 81:185–186.
  • WHITE K, GRETHER ME, ABRAMS JM, YOUNG L, FARRELL K, STELLER H: Genetic control of programmed cell death in Drosophila [see comments]. Science (1994) 264(5159):677–683.
  • DARNAY BG, REDDY SA, AGGARWAL BB: Identification of a protein kinase associated with the cytoplasmic domain of the p60 tumor necrosis factor receptor. J. Biol. Chem. (1994) 269(32):20299–20304.
  • EISCHEN CM, DICK CJ, LEIBSON PJ: Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. (1994) 153(5)1947–1954.
  • HANNUN YA, OBEID LM: Ceramide: an intracellularsignal for apoptosis. Trends Biocbem. Sci. (1995) 20(2):73–77.
  • CIFONE MG, DE MARIA R, RONCAIOLI P, RIPPO MR, AZUMA M, LANIER LL, SANTONI A, TESTI R: Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. Exp. Med. (1994) 180(4):1547–1552.
  • TEWARI M, DIXIT VM: Fas- and tumor necrosis factor-in-duced apoptosis is inhibited by the poxvirus crtnA gene product. J. Biol. Chem, (1995) 270(7):3255–3260.
  • HSU H, XIONG J, GOEDDEL DV: The TNF receptor 1-as-sociated protein TRADD signals cell death and NE-kappa B activation. Cell (1995) 81(4):495–504. One of a clutch of papers describing the cloning of TNF receptor associated proteins.
  • STANGER BZ, LEDER P, LEE TII, KIM E, SEED B: RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell (1995) 81(4):513–523. One of a clutch of papers describing the cloning of TNF receptor associated proteins.
  • BOKA G, ANGLADE P, WALLACH D, JAVOY-AGID F, AGIDY, HIRSCH EC: Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lea. (1994) 172(1-2):151–154.
  • MOGI M, HARADA M, RIEDERER P, NARABAYASHI H, FUJITA K, NAGATSU T: Tumor necrosis factor-a (TNF-a) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients. Neurosci. Lett. (1994) 165(1-2):208–210.
  • FILLIT H, DING WH, BURR L, KALMAN J, ALTSTIEL L,LAWLOR B, WOLF-MEIN G: Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci. Lett. (1991) 129(2):318–320.
  • MEDA L, CASSATELLA MA, SZENDREI GI, OTVOS L JR, BARON P, VILLALBA M, FERRARI D, ROSSI F: Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature (1995) 374(6523):647–650.
  • SELMAJ K, RAINE CS, FAROOQ M, NORTON WT, BROSNAN CF: Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol. (1991) 147(5):1522–1529.
  • CHINNAIYAN AM, O'ROURKE K, TEWARI M, DIXTT VM: FADD, a novel death domain-containing protein, inter-acts with the death domain of Fas and initiates apop-tosis. Cell (1995) 81(4):505–512. One of a clutch of papers describing the cloning of TNF receptor associated proteins.
  • LOS M, VAN DE CRAEN M, PENNING LC, SCHENK H, WESTENDORP M, BAEUERLE PA, DROGE W, KRAMMERPH, HERS W, SCHULZE-OSTHOFF K: Requirement of an ICE/CED-3 protease for Fas/AP0-1-mediated apoptosis. Nature (1995) 375(6526):81–83. This paper presents evidence that the apoptotic activity of the Fas system is mediated by the ICE cysteine protease.
  • TAKAYAMA 5, SATO T, KRAJEWSKI 5, KOCHEL K, IRIE S, MILLAN JA, REED JC: Cloning and functional analysis of BAG-1: A novel Bc1-2 binding protein with anti-cell death activity. Cell (1995) 80:279–284.
  • ITOH N, TSUJIMOTO Y, NAGATA 5: Effect of bc1-2 on Fas antigen-mediated cell death. J. Immunol. (1993) 151(2):621–627.
  • MATSUYAMA T, HATA R, TAGAYA M, YAMAMOTO Y, NAKAJIMA T, FURUYAMA J, WANAKA A, SUGITA M: Fos antigen mRNA induction in postischemic murine brain. Brain Res. (1994) 657(1–2):342-346.
  • ELLIS RE, YUAN J, HORVITZ HR: Mechanisms and functions of cell death. Ann. Rev. Cell Biol. (1991) 7:663–698.
  • YUAN J, SHAHAM S, LEDOUX S, ELLIS HM, HORVITZ HR: The C. elegans cell death gene CED-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell (1993) 75:641–652.
  • GAGLIARDI V, FEF(NANDEZ P, LEE RKK, DREXLER HCA, ROTELLO RJ, FISHMAN MC, YUAN JY: Prevention of vertebrate neuronal death by the crmA gene. Science (1994) 263:826–828.
  • FERNANDES-ALNEMRI T, LITWACK G, ALNEMRI ES: CPP32,a novel human apoptotic protein with homology to Caenorhabaitis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J. Biol. Chem. (1994) 269(49):30761–30764.
  • FERNANDES-ALNEMRI T, LITWACK G, ALNEMRI ES: Mch2,a new member of the apoptotic Ced-3/ICE cysteine protease gene family. Cancer Res. (1995) 55(13):2737–2742.
  • FERNANDES-ALNEMRI T, TAKAHASHI A, ARMSTRONG R, KREBS J, FRITZ L, TOMASELLI KJ, WANG L, YU Z, CROCE CM, SALVESON G, EARNSHAW WC, LITWACK G, ALNEMRI ES: MCH3, a novel human apoptotic cystein protease highly related to CPP32. Cancer Res. (1995) 55(24):6045–6052. Indicative of direction future research will head in pursuit of detailed interactions between ICE protease family members.
  • FAUCHEU C, DIU A, CHAN AW, BLANCHET AM, MIOSSEC C, HEAVE F, COLLARD-DUTIILFUL V, GU Y, ALDAPE RA, LIPPKE JA et aL: A novel human protease similar to the interleukin-1 beta converting enzyme induces apop-tosis in transfected cells. EIVIBO J (1995) 14(91:1914–1922.
  • AMENS J, PASKIND M, HUGUNIN M, TALANIAN RV, ALLEN H, BANACH D, BUMP N., HACKETT M, JOHNSTON CG, LI P, MANKOVICH JA, TERRANOVA M, GHAYUR T: Identification and characterization of Ich-2, a novel member of the interleukin-1 beta-converting enzyme family of cystein proteases. J. Biol. Chem. (1995) 270(25):15250–15256.
  • KUMAR S, KINOSHITA M, NODA M, COPELAND NG, JENKINS NA: Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorbabdit is elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev. (1994) 8(14):1613–1626.
  • MUNDAY NA, VAILLANCOURT JP, ALT A, CASANO FJ, MILLER DK, MOLINEAUX SM, YAMIN TT, YU VL, NICHOL-SON DW: Molecular cloning and pro-apoptotic activity of ICErelll and ICErellll, members of the ICE/CED-3 family of cysteine proteases. J. Biol. Chem. (1995) 270(261:15870–15876.
  • TEWARI M, QUAN LT, O'ROURKE K, DESNOYERS S, ZENGZ, BEIDLER DR, POIRIER GG, SALVESEN GS, DI VM: Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-Inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell (1995) 81(5):801–809.
  • WANG L, MIURA M, BERGERON L, ZHU H, YUAN J: Ich-1,an ICE/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell. (1994) 78:739–750.
  • KUIDA K, LIPPICE JA, KU G, HARDING MW, LIVINGSTONDJ, SU MS, FLAVELL RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta-con-verting enzyme. Science (1995) 267: 2000-2003.
  • NICHOLSON DW, ALI A, THORNBERRY NA, VAILLAN COURT JP, DING CK, GALLANT M, GAREAU Y, GRIFFIN PR, LABELLE M, LAZEBNIK YA et al.: Identification and inhi-bition of the ICE/CED-3 protease necessary for mam-malian apoptosis [see comments]. Nature (1995) 376(65351:37-43. First description of pharmaceutical development of ICE protease inhibitors.
  • BREDESEN DE: Neural apoptosis. Ann. Neurol. (1995) 38(61:839-851. Good review of apoptotic mechanisms in the nervous system.
  • MILLIGAN CE, PREVE'rTE 0, YAGINUMA II, HOMM S, CARDWELL C, FRITZ LC, TOMASELLI KJ, OPPENHEIM RW, SCHWARTZ LM: Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron (1995) 15:385–393.
  • KUMAR S, HARVERY NL: Role of multiple cellular pro-teases in the execution of programmed cell death. FEBS Lett. (1995) 375:169-173. Presents one conceptual framework for looking at ICE protease family interactions.
  • BAKHSHI A, JENSEN JP, GOLDMAN P, WRIGHT JJ, MCBRIDE WW, EPSTEIN AL, KORSMEYER A: Cloning the chromosomal breakpoint of tt(14;18) human lym-phomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell (1985) 41:899–906.
  • CLEARY ML, SKLAR J: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA (1985) 82:7439–7443.
  • TSUJIMOTO Y, GORHAM J, COSSMAN J, JAFFE E, CROCECM: The t(14;18) translocation involved in B-cell neo-plasms result from mistakes in VDJ joining. Science (1985) 229:1390–1333.
  • VAUX DL, CORY S, ADAMS JM: Bc1-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (1988) 335:440–442.
  • HENGARTNER MO, ELLIS RE, HORVITZ HR: Caenorbabdi-tis elegans gene ced-9 protects cells from programmed cell death. Nature. (1992) 356:494–499.
  • BOISE LH, GONZALEZ-GARCIA M, POSTEMA CE, DING L,LINDSTEN T, TURKA LA, MAO X, NUNEZ G, THOMPSON CB: bcl-x, a bc1-2-related gene that functions as a domi-nant regulator of apoptotic cell death. Cell (1993) 74:597–608.
  • CHITTENDEN T, HARRINGTON EA, O'CONNOR R, FLEMINGTON C, LUTZ RJ, EVAN GI, GUILD BC: Induction of apoptosis by the Bc1-2 homologue Bak. Nature (1995) 374:733–736.
  • FARROW SN, WHITE JHM, MARTINOU I, RAVEN T, PUN K,GRINHAM CJ, MARTINOU JC, BROWN R: Cloning of a lbc1-2 homologue by interaction with adenovirus ElB 19K. Nature (1995) 374:731–733.
  • KIEFER MC, BRAUER MJ, POWERS VC, WU JJ, UMANSKYSR, TOMEI LD, BARR PJ: Modulation of apoptosis by the widely distributed Bc1-2 homologue Bak. Nature (1995) 374(6524):736–739.
  • KOZOPAS KM, YANG T, BUCHAN ILL, ZHOU P, CRAIG RW:MCL-1, a gene expressed in programmed myeloid cell differentiation has sequence similarity to Bc1-2. Proc. Natl. Acad. Sci. USA. (1993) 90:3516–3520.
  • OLTVAI ZN, MILLIMAN CL, KORSMEYER SJ: Bel-2 heterodi-merizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell (1993) 74:609–619.
  • YANG E, ZHA J, JOCKEL J, BOISE LH, THOMPSON CB, KORSMEYER SJ: Bad, a Heterodhneric Partner for Bc1-xL and Bc1-2, displaces Bax and promotes cell death. Cell (1995) 80:285–291.
  • LIN EY, ORLOFSKY A, BERGER MS, PRYSTOWSKY MB: Characterization of Al, a novel hemopoietic-specific early-response gene with sequence similarity to Bc1-2. J. Immunol. (1988) 151:1979–1988.
  • YIN XM, OLTVAL ZN, KORSMEYER SJ: BH1 and BH2 domains of Bc1-2 are required for inhibition of apop-tosis and heterodimerization with Bax. Nature (1994) 369(6478):321–323.
  • KRAJEWSKI K, TANAKA S, TAKAYAMA S, SCHIBLER MG, FENTON W, REED JC: Investigation of the subcellular distribution of the bc1-2 oncoproteim Residence in the nuclear envelope, endoplasmic retkulum, and outer mitochondrial membranes. Cancer Res. (1993) 53:4701–4714.
  • HOCKENBERY DM, OLTVAI ZN, YIN XM, MILLIMAN CL, KORSMEYER SJ: Bc1-2 functions in an antioxidant path-way to prevent apoptosis. Cell (1993) 75(2):241–251.
  • KANE DJ, SARAFIAN TA, ANTON R, HAHN H, GRALLA EB,VANLENTINCE JS, ORD T, BREDESEN DE: Bc1-2 inhibition of neural death: decreased generation of reactive oxy-gen species. Science. (1993) 262:1274–1277.
  • CRAIG RW: The BcI-2 gene family. Sem. CancerBiol. (1995)6:35–43.
  • DAVIES AM: The Bc1-2 family of proteins, and the regulation of neuronal survival Trends Neurosci. (1995) 18(8):355–358. Good introduction to Bc1-2 area with emphasis on nervous system.
  • GARCIA I, MARTINOU I, TSUJIMOTO Y, MARTINOU JC: Prevention of programmed cell death of sympathetic neurons by the bc1-2 proto-oncogene. Science (1992) 258:302–304.
  • MARTINOU JC, DUBOIS-DAUPHIN M, STAPLE JK, RO-DRIGUEZ I, FRANKOWSKY J, MISSOTTEN M, ALBERTINI P, TALABOT D, CATSICAS S, PIETRA C, HUARTE J: Overex-pression of bc1-2 In transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron (1994) 13:1–20.
  • VEIS DJ, SORENSON CM, SHUTTER JR, DORSMEYER SJ:Bc1-2 deficient mice demonstrate fuhninant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell (1993) 75:229–240.
  • MOTOYAMA N, WANG F, ROTH KS, SAWA H, KAKAYAMARI, NAKAYAMA K, NEGISHI I, SENJU S, ZHANG Q, FUJII S, LOH DY: Massive cell death of immature hematopoietic cells and neurons in Bc1-x-deficient mice. Science (1995) 267:1506–1510.
  • KRAJEWSKI S, MAI JK, KRAJEWSKA M, SIKORSKA M, MOSSAKOWSKI MJ, REED JC: Upregulation of bax proteinlevels in neurons following cerebral ischemia. J. Neuro-sci. (1995) 15(10):6364–6376. Well-controlled study implicating the bc1-2 family in global ischemia
  • WYLLIE AH: Glucocorticold-induced thymocyte apop-tosis is associated with endogenous endonuclease acti-vation. Nature (1980) 284 (5756):555–556 .
  • TOMEI LD, SHAPIRO JP, COPE FO: Apoptosis in C3H/10T1/2 mouse embryonic cells: evidence for inter-nucleosomal DNA modification in the absence of dou-ble-strand cleavage. Proc. Natl. Acad. Set. USA (1993) 90(3):853–857.
  • BARRY MA, EASTMAN A: Identification of deoxyribonu-clease II as an endonuclease involved In apoptosis. Arch. Biochem. Biophys. (1993) 300(1):440–450.
  • UCKER DS, OBERMILLER PS, ECKHART W, APGAR JR, BERGER NA, MEYERS J: Genome digestion is a dispensa-ble consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol. Cell. Biol. (1992) 12(7):3060–3069.
  • CARON-LESLIE LM, SCIIWARTZMAN RA, GAIDO ML, COMPTON MM, CIDLOWSKI JA: Identification and char-acterization of glucocorticoid-regulated nudease(s) in lymphoid cells undergoing apoptosis. J. Steroid Biochem. Mol. Biol. (1991) 40(4-6):661–671.
  • PEITSCH MC, B. POLZAR B, H. STEPHAN H, T. CROMPTONT, MACDONALD HR, MANNHERZ HG, TSCHOPP J: Char-acterization of the endogenous deoxyribonuclease in-volved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J. (1993) 12(1):371–377.
  • OBERHAMMER F, WILSON jw, DIVE C, MORRIS ID, HICK-MAN JA, WAKELING AE, WALKER PR, SIKORSKA M: Apop-totic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. (1993) 12(9):3679–3684.
  • FILIPSKI J, LEBLANC J, YOUDALE T, SIKORSKA M, WALKERPR: Periodicity of DNA folding in higher order chroma-tin structures. EMBOJ (1990) 9(4):1319–1327.
  • TIIOMPSON CB: Apoptosis in the pathogenesis and treatment of disease. Science (1995) 267:1456–1462.
  • STELLER H: Mechanisms and genes of cellular suicide.Science (1995) 267:1445–1449.
  • DRAGUNOW M, PRESTON K: The role of inducibk transscription factors in apoptotic nerve cell death. BrainRes. Rev. (1995) 21:1-28. A review of apoptosis and anti-apoptotic genes and the role of transcription factors in nerve cell death
  • LO AC, HOUENOU LJ, OPPENHEIM RW: Apoptosis lathe nervous system: morphological features, methods, pa-thology, and prevention. Arch. Histol. Cytol. (1995) 58(2):139–149.
  • ESTEVEZ AG, RADI R, BARBEITO L, SHIN JT, THOMPSONJA, BECKMAN JS: Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism dif-ferentially modulated by neurotrophic factors. J. Neuro-chem. (1995) 65:1543–1550.
  • CHOI DW: Cerebral hypoxia: some new approaches and unanswered questions. J. Neurosci. (1990) 10:2493–2501.
  • SIMS NR, ZAIDAN E: Biochemical changes associated with selective neuronal death following short-term cerebral ischemia. Int. J. Biochem. Cell Biol. (1995) 27(6):531–550.
  • COYLE JT, PUTFFARCKEN P: Oxidative stress, glutamate, and neurodegenerative disorders. Science (1993) 262:689–695.
  • LINNIK MD, ZOBRIST RH, HATFIELD MD: Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke (1993) 24:2002-2009. Pivotal early paper assessing the role of apoptosis in focal ischemia
  • MACMANUS JP, BUCHAN AM, HILL IE, RASQUINHA I, PRESTON E: Global ischemia can cause DNA fragmenta-tion indicative of apoptosis in rat brain. Neuroscience Lett. (1993) 164(1-2):89–92.
  • OKAMOTO M, MATSUMOTO M, ONTSUKI T, TAGUICHI A,M1KOSHITA K, YANAGIHARA T, KAMADA T: Internu-cleosomal DNA cleavage involved in ischemia-induced neuronal death. Biochem. Biophys. Res. Commun. (1993) 196(3):1356–1362.
  • KURE S, TOMINAGA T, YOSIIIMOTO T, TADA K, NARI-SAWA K: Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem. Biophys. Res. Com-mun. (1991) 179(1):39–45.
  • DESSI F, CHARRIAUT-MARLANGUE C, KEIRESTCHATISICY M, BEN-ARTY: Glutamate-induced neuronal death is not a programmed cell death in cerebellar culture. J. Neuro-chem. (1993) 60(5)1953–1955.
  • CHOI DW, KOH K, DEMARO JA, YING HS, JACQUIN MF, GWAG VJ: Even slowly triggered exchotoxic neuronal death of cultured cortical neurons occurs by necrosis not apoptosis. 25th Soc. Neurosci. San Diego, USA (1995) 21:1585.
  • ANKARCRONA M, DYPBUKT JM, BONFOCO E, ZHIVO-TOVSKY B, ORRENIUS S, LIPTON SA, NICOTERA P: Gluta-mate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron (1995) 15:961–973.
  • GWAG BJ, LOBNER D, KOH JY, WIE MB, CHOI DW: Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neuroscience (1995) 68(3):615–619.
  • KOH J-Y, PALMER E, COTMAN CW: Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures. Proc. Natl. Acad. Sci. USA (1991) 88:9431–9435.
  • COPANI A, BRUNO VMG, BARRESI V, BATTAGLIA G, CONDORELLI DF, NICOLETTI F: Activation of metabot-ropic glutamate receptors prevents neuronal apoptosis in culture. J. Neurochem. (1995) 64(1):101–108.
  • JOHNSON EM, GREENLUND US, AKINS PT, HSU CY: Neuronal apoptosis: current understanding of molecu-lar mechanisms and potential role in ischemic brain injury. J. Neurotrauma (1995) 12(5)843-852. In depth review of the molecular genetic components of apoptosis that characterize in vitro neuronal cell death as well as mechanisms of cell death in vivo following ischemia
  • PULSINELLI W, BRIERLEY J, PLUM F: Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. (1982) 11:491.
  • OKAMOTO M, MATSUMOTO M, OHTSUKI T, TAGUCHI A, MIKOSHIBA K, YANAGIHARA T, KAMADA T: Internu-cleosomal DNA cleavage involved in ischemia-induced neuronal death. Biochem. Biophys. Res. Commun. (1993) 196(3):1356–1362.
  • SET Y, VON LL;BITZ DKJE, BASILE AS, BORNER MM, UN RCS, SKOLNICK P, FOSSOM LH: Internucleosomal DNA fragmentation in gerbil hippocampus following fore-brain ischemia. Neurosci. Lett. (1994) 171:179–182.
  • NITATORI T, SATO N, WAGURI S, KARASAWA Y, ARAKI H, SHIBANAI K, KOMINAMI E, UCHIYAMA Y: Delayed neuro-nal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apop-tosis. J. Neurosci. (1995) 15(2):1001–1011.
  • MEHMET H, YUE X, SQUIER MV, EDWARDS AD: The relationship between impaired cerebral energy meta-bolism and apoptosis in the cingulate gyros of newborn piglets following transient hypoxia-ischaemia. Bio-chem. Soc. Trans. (1994) 22:421S.
  • MACMANUS JP, BUCHAN AM, HILL IE, RASQUINHA I, PRESTON E: Global ischemia can cause DNA fragmenta-tion indicative of apoptosis in rat brain. Neurosci. Lett. (1993) 164:89-92. Pivotal early paper on the role of apoptosis in global ischemia
  • HERON A, POLLARD H, DESSI F, MOREAU J, LASBENNES F, BEN-ARTY, CHARRIAUT-MARLANGUE C: Regional vari-ability in DNA fragmentation after global ischemia evidenced by combined histological and gel electro-phoresis observations in the rat brain. J. Neurocbem. (1993) 61:1973–1976.
  • ISLAM N, AFTABUDDIN M, MORIWAKI A, HORI Y: Detec-tion of DNA damage induced by apoptosis in the rat brain following incomplete ischemia. Neuroscl. Lett. (1995) 188:159–162.
  • DESHPANDE J, BERGSTEDT K, LINDEN T, KALIMO H, WEILOCH T: Uhrastructural changes in the hippocam-pal CA1 region following transient cerebral ischemia: evidence against programmed cell death. Exp. Brain Res. (1992) 88:91–105.
  • DRAGUNOW M, YOUNG D, HUGHES P, MACGIBBON G, LAWLOR P, SINGLETON K, SIRIMANNE E, BEILHARZ E, GLUCKMAN P: Is c-Jun involved in nerve cell death following status epilepticus and hypoxic-ischaemic brain injury. Mol. Brain Res. (1993) 18:347-352. Discussion of the possible role of apoptosis in epilepsy
  • DRAGUNOW M, BEILHARZ E, SLRIMANNE E, LAWLOR P, WILLIAMS C, BRAVO R, GLUCKMAN P: Immediate-early gene protein expression in neurons undergoing de-layed death, but not necrosis, following hypoxic-is-chaemic injury to the young rat brain. Mol. Brain Res. (1994) 25:19–33.
  • MCGAHAN L, ROBERTSON GS, HAKIM AM: Expression of Myc and p53 following transient global ischemia. 25th Soc. Neurosci. San Diego, USA (1995) 21:992.
  • JIN ILL, NAKAYAMA M, BOTSCHELLER M, GRAHAM SH, SIMON RP, CHEN J: GADD45 MRNA is persistently ex-pressed in vulnerable neurons following global cere-bral ischemia in the rat. 25th Soc. Neurosci. San Diego, USA (1995) 21:992.
  • NAKAYAMA M, CILEN J, LOWRY T, ASAKURA T, GRAHAM SH: The immediate early gene cyclooxygenase-2 is ex-pressed in CA1 neurons destined for apoptotic death following global ischemia. 25th Soc. Neurosci. San Diego, USA (1995) 21:1268.
  • ZHANG RU, CHOPP M, CIIEN II, GARCIA JH: Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and tran-sient (211) middle cerebral artery occlusion in the rat. J. Neurol. Sci. (1994) 125:3–10.
  • MACMANUS JP, HILL IE, HUANG Z-G, RASQUINHA I, XUED, BUCHAN AM: DNA damage consistent with apoptosis In transient focal ischaemic neocortex. NeuroReport. (1994) 5:493–496.
  • LI Y, CHOPP M, JIANG N, YAO F, ZALOGA C: Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. (1995) 15:389–397.
  • LI Y, CHOPP M, JIANG N, ZFIANG ZG, ZALOGA C: Induc-tion of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke. (1995) 26(7):1252–1258.
  • LI Y, SHAROV YG, JIANG N, ZALOGA C, SABBAH HN, CHOPP M: Ultrastructural and light microscopic evi-dence of apoptosis after middle cerebral artery occlu-sion in the rat. Am. J. Pathol. (1995) 146(5)1045–1051.
  • VAN LOOKEREN CAMPAGNE M, KOHLER C., GILL R: Ex-pression of p53 and cycling in nuclei of cells undergo-ing ischaemia-induced apoptosis in the rat brain. 25th Soc. Neurosci. San Diego, USA (1995) 21:992.
  • CHARRIAUT-MARLANGUE C, MARGAILL I, PLOTKINE M, BEN-ART Y: Early endonuclease activation following reversible focal ischemia in the rat brain.]. Cereb. Blood Flow Metab. (1995) 15:385–388.
  • GOHIL K, SINGH T, XUE D, MILIJANICH G, LUTHER RR, BITLER CM, BOWERSOX SS: Neuronal N-type calcium channel antagonist, SNX-111, prevents apoptosis in a focal model of ischemia. 25th Soc. Neurosci. San Diego, USA (1995) 21:1031.
  • KIESSLING M, GASS P: Stimulus-transcription coupling in focal cerebral ischemia. Brain Pat hol. (1994) 4:77–83.
  • LIU T, CLARK RK, MCDONNEL PC, YOUNG PR, WHITE RF, BARONE FC, FEUERSTEIN GZ: Tumor necrosis factor-a expression in ischemic neurons. Stroke (1994) 25:1481–1488.
  • CHEN J, GRAHAM SfI, CHAN PH, LAN J, ZHOU RL, SIMON RP: bc1-2 is expressed in neurons that survive focal ischemia in the rat. NeuroReport (1995) 6:394–398.
  • PREHN JHM: In vivo pattern of BCL-2, BAX and BCL-X expression in mouse neocortex: effect of cerebral is-chemia. 25th Soc. Neurosci. San Diego, USA (1995) 21:512.
  • SIMON RP, CHEN J, ZHU RL, LAN JO, GREENBERG DA, GRAHAM SH: Aheration in anti-apoptotic gene expression associated with induction of tolerance to focal ischemia. 25th Soc. Neurosci, San Diego, USA (1995) 21:512. Describes innovative use of ischemic tolerance to assess role of apoptosis in ischemia
  • CRUMR1NE RC, THOMAS AL, MORGAN PF: Attenuation of p53 expression protects against focal ischemic damage In transgenic mice. J. Cereb. Blood Flow Metab. (1994) 14:887–891.
  • KAMME F, 13ABITY J, ROBERTSON H, WIELOCH T: Differ-ential display PCII and transient forebrain ischemia in the rat. 25th Soc. Neurosci. San Diego, USA (1995) 21:991.
  • Regan, RF, Choi DW: Excitotoxicity and central nervous system trauma. In: The Neurobiology of Central Nervous System Trauma. Salzman SD and Faden Al (Eds.), Oxford University Press, New York. (1994) 173–181
  • MCINTOSH TK, V1NK R, NOBLE L, YAMAKAMI I, FERNYAK S, SOARES H, FADEN LA: Traumatic brain injury in the rat: characterization of a lateral fluid-percussion modeL Neuroscience. (1989) 28:233–244.
  • RINK A, FUNG K-M, TROJANOWSKI JQ, LEE VM-Y, NEUGE-BAUER E, MCINTOSH TK: Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am.], Pathol. (1995) 147(6):1575–1583
  • CONTI A, HYLTON CM, RAGHUPATIII R, SMITH DH, TRO-_JANOWSKI JQ, LEE V, MCINTOSH TIC: Magnesium defi-ciency decreases the occurrence of apoptosis after traumatic brain injury. 13th Annual Neurotrauma Sympo-sium. San Diego, USA (1995).
  • SINSON, G., B. PERRI, J. Q. TROJANOWSKI, V. M.-Y. LEE, AND T. K. MCINTOSH: Apoptotic cell death in the septal nuclei after fluid-percussion brain injury is attenuated by NGF infusion. 13th Annual Neurotrauma Symposium. San Diego, USA (1995)13:976.
  • HAYES RL: Session chairperson's overview of cellular and molecular mechanisms of brain injury. Discoveries in Head Trauma: New Understanding for Novel Therapeutic Development. Philadelphia, USA (1995).
  • YANG K: Intracellular changes in signal transduction, transcription factors and immediate early genes. In: Discoveries in Head Trauma: New Understanding for Novel Therapeutic Development, Philadelphia, USA. (1995).
  • RAGHUPATHI R, MCINTOSH TK: Programmed cell death In traumatic brain injury: temporal alterations in bc1-2 immunoreactivity. 13th Annual Neurotrauma Symposium. San Diego, USA (1995) 13:966.
  • Francel PC, Jane JA, Kroni I: A model of spinal cord ischemia. In: Central Nervous System Trauma: Research Techniques. Ohnishi ST, Ohnishi T (Eds.) CRC Press, Inc. New York (1995) 267–280.
  • CROWE MJ, SHUMAN SL, MASTERS JN, BRESNAHAN JC, BEATTIE MS: Morphological evidence suggesting apop-toile nuclei in spinal cord injury. 25th Soc. Neurosci. San Diego, USA (1995) 21:232
  • COTMAN CW, ANDERSON JA: A potential role for apopstosis in neurodegeneration and Alzheimer's Disease. Mol. Neurobiol. (1995) 10:19-45. Comprehensive review discussing rationale for apoptosis in Alzhe-imer's Disease
  • COTMAN CW, \WHITTEMORE ER, WATT JA, ANDERSON AJ,LOO DT: Possible role of apoptosis in Alzheimer's disease. Ann. NY Acad. Sci. (1994) 747:36-49. Comprehensive review discussing rationale for apoptosis in Alzhe-imer's disease
  • LOO DT, COPANI A, PIKE CJ, WHITTEMORE RR, WALENCEWICZ AJ, COTMAN CW: Apoptosis is induced by 13-amyloid in cultured central nervous system neu-rons. Proc. Natl. Acad. Sci. USA (1993) 90:7951–7955.
  • FORLONI G, CHIESA R, SMIROLDO S, VERGA L, SALMONAM, TAGLIAVINI F, ANGERETTI N: Apoptosis mediated neurotoxicity induced by chronic application of 11 amyloid fragment 25-35. NeuroReport. (1993) 4:523–526.
  • BEIIL C, DAVIS JB, KLIER FG, SCIILTBERT D: Amyloid 13 peptide induces necrosis rather than apoptosis. Brain Res. (1994) 645:253–264.
  • GSCHWIND M, HUBER G: Apoptotic cell death induced by 13 amyloid 1_42 peptide is cell type dependent J. Neurochem. (1995) 65(1):292–300.
  • KUSIAK JW, SISODIA SS, ZHAO B: Apoptosis is induced by expression of mutant amyloid precursor protein in neuronal cells. In: Neurodegenerative Disorders: Common molecular mechanisms, the decade of the brain. Rios, Jamaica (1995) IX:Apoptosis and neurodegenerative disorders.
  • BUSCIGLIO J, YANKNER BA: Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. (1995) 378:776-779. This report demonstrates the relationship between early onset Alzheimer's disease in Down's syndrome sufferes and ROS metabo-lism.
  • ZHANG L, KUSIAK jW, ZHAO B, ROTH GS: Generation of arnyloidogenic Alzheimer's amyloid precursor protein fragments during H202 induced apoptosis in human neuronal cells. 25th Soc. Neurosci. San Diego, USA (1995) 21:1724.
  • SU J11, ANDERSON AJ, CUMMINGS 1:11, COTMAN CW: Im-munohistochemical evidence for apoptosis in Alzhe-imer's disease. NeuroReport. (1994) 5:2529–2533.
  • SU JH, ANDERSON AJ, COTMAN CW: Quantitative assess-ment of apoptotic-like nuclei in hippocampal formation of Alzheimer brain. 25th Soc. Neurosci. San Diego, USA (1995) 21:1727.
  • DRAGUNOW M: DNA fragmentation in Alzheimer's Dis-ease hippocampus: correlation with tau and ll-amyloid immunoreactivity. 25th Soc. Neurosci. San Diego, USA (1995) 21:1724.
  • ANDERSON AJ, SU JH, COTMAN CW: DNA damage and apoptosis in Alzheimer's Disease colocalization with c-Jun immunoreactivity, relationship to brain area, and effects of postmortem delay. J. Neurosci. (1996) 16(5):1710–1719.
  • LASSMAN H, BANCHER C, BREITSCHOPF H, WEGIEL J, BOBINSKI M, JELLINGER K, WISNIEWSKI HM: Cell death In Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. (1995) 89:35–41.
  • PERLMUTTER LS, BUSHNELL AF, LI Y-P, WEBSTER S, WONG S: Evidence for DNA damage, but not apoptosis, in Alzheimer's Diseased (AD) brain. 25th Soc. Neurosci. San Diego, USA (1995) 21:1721.
  • MIGHELI A, CAVALLA P, PIVA R, GIORDANA MT, SCIIIFFER D: bc1-2 protein expression in aged brain and neurode-generative diseases. NeuroReport. (1994) 5:1906–1908.
  • SATOU T, CUMMINGS BJ, COTMAN CW. BCL-2 protein immunoreactivity increases in Alzheimer's Disease brain with disease severity. 25th Soc. Neurosci. San Diego, USA (1995) 21:1726.
  • O'BARR S, SCHULTZ J, MCKINLEY M, ROGERS J: Expres-sion of BCL-2 oncoprotein in Alzheimer's Disease. Soc. Neurosci. Abstr. (1995)
  • JOHNSON EM: Possible role of neuronal apoptosis in Alzhehner's disease. Neurobiol. Aging (1994) 15(2):S187–S189.
  • LAFERLA FM, TINKLE BT, BIEBERICH CJ, HAUDENSCIIILD CC, JAY G: The Alzheimer's Al peptide induced neurode-generation and apoptotic cell death in transgenic mice. Nat. Genet. (1995) 9:21-30. Innovative use of a transgenic model to link MP, cell death and apoptosis
  • VITO, P., E. LACANA, L. D'ADAMIO. Interfering with apoptosis: Ca2. -binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science (1996) 271:521–525.
  • MCDONALD WI, SILBERGERG DH: Multiple Sclerosis. But-terworths, London. (1986).
  • DUBOIS-DALQ M, ARMSTRONG R: The cellular and mo-lecular events of central neurons remyelination. BioEs-says (1990) 12:569–576.
  • BARRES BA, HART IK, COLES HSR, BURNE JF, VOYVODIC JT, RICHARDSON WD, RAFF MC: Cell death and control of cell survival in the oligodendrocyte lineage. (1992)Cell 70:31–46.
  • KNAPP PE, SKOFF RP, REDSTONE WR: Oligodendroglial cell death in jimpy mice: an explanation for the myelin deficit. J. Neurosci (1986) 6(10):2813–2822
  • PENDER MP, BNGUYEN KB, MCCOMBE PA, KERR JER: Apoptosis in the nervous system in experimental aller-gic encephalomyelitis. J. Neurol. Sci. (1991) 104:81–87.
  • PRABHAKAR S, D'SOUZA S, ANTEL JP, MCLAURIN JA, SC1IIPPER TIM, WANG E: Phenotypic and cell cycle prop-erties of human oligodendrocytes in vitro. Brain Res. (1995) 672: 159–169.
  • MUIR D, COMPSTON DAS: Growth factor stimulation triggers apoptotic cell death in mature rat oligodendro-cytes. J. Neurosci. Res. (1996) in press.
  • SCOLDING NJ, HOUSTON WAJ, LININGTON C, MORGAN BP, CAMPBELL AK, COMPSTON DAS: Oligodendrocytes activate complement but recover by vesicular removal of membrane attack complexes. Nature (1989) 338:620–622.
  • WREN DR, NOBLE M: Oligodendrocytes and oligoden-drocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of com-plement in the absence of antibody. Proc. Natl. Acad. Sci. USA (1989) 86:9025–9029.
  • WOOD A, WING M, BENHAM CD, COMPSTON DAS: Spe-cific induction of intracellular calcium oscillations by complement membrane attack on oligodendroglia. J. Neurosci. (1993) 13:3319–3332.
  • TABI Z, MCCOMBE PA, PENDER MP: Apoptoic elimination of V beta 8.2+ cells from the central nervous system during recovery from experimental autoimmune en-cephalomyelitis induced by the passive transfer of V beta 8.2+ encephalitogenic T cells. Eur.J.Immunol. (1994) 24:2609–2617.
  • PELFREY CM, TRANQUILL LR, BOEHME SA, MCFARLAND I-IF, LENARDO MJ: Two mechanisms of antigen-specific apoptosis of myelin basic protein (M13P)-specific T lymphocytes derived from multiple sclerosis patients and normal Individuals.]. linniunol. (1995) 154(11):6191–6202.
  • TROY CM, SHELANSKI ML: Down-regulation of cop-per/zinc superoxide dismutase causes apoptotic death In PC12 neuronal cells. Proc. Natl. Acad. Sci. USA (1994) 91:6384–6387.
  • GREENLUND LS, DECKWERTH TLJOHNSON EM Jr: Super-oxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron (1995) 14:303–315.
  • ROTHSTEIN JD, BRISTOL LA, HOSIER B, BROWN RH, JR., KUNCL RW: Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc. Natl. Acad. Sci. USA (1994) 91:4155–4159.
  • RABIZADEH S, GRALLAEB EB, BORCIIELT DR, GWINN R, VALENTINE JS, SISODIA 5, WONG P, LEE M, HAIIN H, BREDESEN DE: Mutations associated with aniyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA (1995) 92:3024-3028. This report indicates that the apoptotic inhibition by SOD1 is not a function of its enzymatic activity. The system described might be a valuable model to identify the mechanism by which familial amyot-rophic lateral sclerosis-associated SOD1 mutations cause neural cell death.
  • MU X, 11E1 ANDERSON DW, TROJANOWSKI JQ, SPRINGER JE: Altered expression of bc1-2 and bay mRNA in amyot-rophic lateral sclerosis motoneurons. 25th Soc. Neurosci. San Diego, USA. (1995) 21:561.
  • DUBOIS-DAUPHIN M, FRANKOWSKI II., TSUJIMOTO Y, IRIARTE J, MARTINOU JC: Neonatal motoneurons over-expressing the Bc1-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc. Natl. Acad. Sci. USA (1994) 91: 229–24 0.
  • BARDE YA: Trophic factors and neuronal survival Neu-ron (1989) 2:1525–1534.
  • THOENEN H, BARDE FA, DAVIES AM, JOHNSON JE: Neurotrophic factors and neuronal death. In: Selective neuronal death. Ciba Found. Symp. (1987) 126:82–95.
  • LINDSAY RM: Neuron savings schemes. Nature (1995) 373:289–290.
  • BARINGA M: Neurotrophic factors enter the clink. Sci-ence (1994) 264:272–274.
  • WALKINSHAW G, Waters CM: Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience (1994) 63(4):975–987.
  • WALKINSHAW G, WATER CM: Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA: Implications for the treatment of Parkinson's Disease. J. Clin. Invest. (1995) 95:2458–2464.
  • DEXTER DT, CARAYON A, VIDAILHET M, RUGERB M, AGID F, AGID Y, LEES AJ, WELLS FR, JENNER P, MARSDEN C: Decreased ferrititt levels in brain in Parkinson's dis-ease. J. Neurochern. (1990) 55:16–20.
  • HARTLEY A, STONE JM, HERON C, COOPER JM, SCHAPIRA AHV: Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's Dis-ease. J. Neurochem. (1994) 63(5): 1987–1990.
  • DISPASQLIALE B., MARINI AM, YOULE RJ: Apoptosis and DNA degradation induced by 1 methy1-4-phenylpyrid-inium in neurons. Biochem. Biophys. Res. Commun. (1991) 181(3):1442–1448.
  • MITCHELL IJ, LAWSON S, MOSE B, LAIDLAW SM, COOPER AJ, WALKINSHAW G, WATERS CM: Glutamate-induced apoptosis results in a loss of striatal neurons in the Parkin.sonian rat. Neuroscience. (1994) 63(1): 1–5. Elegant paper using a drug-induced model of Parkinson's Disease to assess apoptotic mechanisms
  • JANSON AM: Apoptosis-like neuronal cell death in vivo In the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) mouse model of Parkinson's disease. 25th Soc. Neurosci. San Diego, USA (1995) 21:1273.
  • JACKSON-LEWIS V, JAKOWEC MW, BURKE RE, PRZEDBOR-SKI S: Time course and morphology of MPTP-induced neuronal death. 25th Soc. Neurosci. San Diego, USA (1995) 21:2002.
  • PORTERA-CAILLIAU C, HEDREEN JC, PRICE DL, KOLLATSOS VE: Evidence for apoptotic cell death in Hung-tington disease and excitotoxic animal models. J. Neurosci. (1995) 15(5):3775–3787. Rationale for the role of apoptosis in Huntington's Disease
  • POLLARD H, CANTAGREL S, CHARRIAUT-MARLANGUE C, MOREAU J, BEN-AM Y: Apoptosis associated DNA fragmentation in epileptic brain damage. Neuroreport. (1994) 5:1053-1055. Discussion of the possible role of apoptosis in epilepsy
  • ROY N, MAHADEVAN MS, MCLEAN M, SHUTLER G, YARAGHI Z, FARAHANI R, BAIRD S, BESNER-JOHNSTON A, LEFEBVRE C, KANG X, SALIFI M, AUBRY H, TAMAI K, GUAN X, LOANNOU P, CRAWFORD TO, DEJONG PJ, SURH L, IKEDA J-K, KORNELUK RG, MACKENZIE A: The gene for neuronal apoptosis inhibitory protein is partially de-leted in individuals with spinal muscular atrophy. Cell (1995) 80:167–178.
  • SESHADRI T, RODMAN L, SHI L, WARDWELL S, WEI FY, ALLEN II, GREENBERG AFT, LI P, BANERJEE S: Apoptosis In u-113 converting enzyme (ICE)-defIcient mice. In: Programmed Cell Death. Cold Spring Harbor, NY (1995) 72.

References to Patent Literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.